Fig. 1From: ι-Carrageenan nanocomposites for enhanced stability and oral bioavailability of curcuminSchematic illustration of the (A) fabrication method and (B) absorption route of orally administered free curcumin or curcumin nanocomposites (Cur@CRN) in the small intestine. (C) Interaction between sulfate groups (SO42−) in carrageenan and SLC26A2 that affect active transportBack to article page